With 0.55 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.58 million shares. The 52-week range on NRDS shows that it touched its highest point at $17.11 and its lowest point at $9.88 during that stretch. It currently has a 1-year price target of $16.50. Beta for the stock currently stands at 1.39.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of NRDS was down-trending over the past week, with a drop of -5.53%, but this was down by -30.67% over a month. Three-month performance dropped to -30.43% while six-month performance fell -23.49%. The stock lost -41.32% in the past year, while it has lost -25.56% so far this year. A look at the trailing 12-month EPS for NRDS yields 0.40 with Next year EPS estimates of 0.65. For the next quarter, that number is -0.10. This implies an EPS growth rate of -18.86% for this year and 111.35% for next year. EPS is expected to grow by 25.99% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 0.94%.
Float and Shares Shorts:
At present, 42.42 million NRDS shares are outstanding with a float of 34.56 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for NRDS since 5 analysts follow the stock currently. There are 5 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.06151536 being high and -$0.15818 being low. For NRDS, this leads to a yearly average estimate of -$0.096667. Based on analyst estimates, the high estimate for the next quarter is $0.19 and the low estimate is $0.19. The average estimate for the next quarter is thus $0.19.
Summary of Insider Activity:
Insiders traded NRDS stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has remained unchanged to 0 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 0 while 0 shares were sold.
